Mycopathologia et mycologia applicata

, Volume 30, Issue 2, pp 97–114 | Cite as

An aquatic fungal bio-assay method for detection of carcinostatic agents

  • P. A. Volz
  • E. S. Beneke


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ammann, C. A. &R. S. Safferman. 1958. The onion test as a possible screening method for antitumor agents. Antibiot. and Chemother.8: 1–7.Google Scholar
  2. 2.
    Asheshov, I. N., E. A. Hall &H. Flon. 1955. Action of test compounds on bacterial viruses. Amer. Ass. Cancer Res., Inc. Cancer Res. Suppl.3: 57–62.Google Scholar
  3. 3.
    Becker, Z. E., T. P. Suprun, E. G. Rodionova &T. V. Iangulova. 1961. Cytotoxic properties of extracts from fungal mycelium. Antibiotiki6: 108–111.PubMedGoogle Scholar
  4. 4.
    Bieber, S. &G. H. Hitchings. 1955. The developing frog embryo and growth inhibitors. Cancer Res. Suppl.3: 80–82.PubMedGoogle Scholar
  5. 5.
    Bradner, W. T. 1958. Special microbiological systems I. Anaerobic organisms. Ann. N. Y. Acad. Sci.76: 469–474.PubMedGoogle Scholar
  6. 6.
    Bradner, W. T. &D. A. Clarke. 1958. Inhibition of anaerobic bacteria as a screen for antitumor agents. Cancer Res.18: 299–304.PubMedGoogle Scholar
  7. 7.
    Bradner, W. T., A. Roth, B. Weiss &D. A. Clarke. 1957. Inhibition of anaerobic bacteria for various antitumor agents. Bact. Proc.36: 24–27.Google Scholar
  8. 8.
    Clarke, D. A. 1955. Mouse Sarcoma 180. Cancer Res. Suppl.3: 14–17.PubMedGoogle Scholar
  9. 9.
    DiPaolo, J. A. &P. Rosenfield. 1958. The use of anaerobes as a screening procedure for potential tumor inhibiting agents. Proc. Amer. Ass. Cancer Res.2: 292.Google Scholar
  10. 10.
    Endicott, K. M. 1958. Introduction. Ann. N. Y. Acad. Sci.76: 411.Google Scholar
  11. 11.
    Foley, G. E. 1956. Observations on the use of microbiological systems in screening potential antitumor agents. Current Res., Cancer Chemother. Rep.6: 3–22.Google Scholar
  12. 12.
    Foley, G. E., H. Eagle, E. E. Snell, G. W. Kidder &P. S. Thayer. 1958. Studies on the use ofin vitro procedures for the screening of potential antitumor agents: Comparison of activity in mammalian cell cultures and microbiological assays alone and in combination with experimental antitumor activity. Ann. N. Y. Acad. Sci.76: 952–960.PubMedGoogle Scholar
  13. 13.
    Foley, G. E., R. E. McCarthy, V. M. Binus, E. E. Snell, B. M. Guirard, G. W. Kidder, V. C. Dewey &P. S. Thayer. 1958. A comparative study of the use of microorganisms in the screening of potential antitumor agents. Ann. N. Y. Acad. Sci.76: 411–441.Google Scholar
  14. 14.
    Gause, G. F., G. V. Kochetkova &G. V. Vladimiruva. 1959. Action of anticancer substances upon the biochemical mutants of microorganisms with impared oxidation. Cancer Chermother. Rep. CCNSC. p. 48–51.Google Scholar
  15. 15.
    Gause, G. F. 1958. The search for anticancer antibiotics. Science127: 506–508.PubMedGoogle Scholar
  16. 16.
    Gellhorn, A. 1959. Invited remarks on the current status of research in clinical cancer chemotherapy. Cancer Chemother. Rep. CCNSC. p. 1–12.Google Scholar
  17. 17.
    Hirschberg, E. 1955. Some contributions of microbiology to cancer research. Bact. Rev. (reprint).19, 2.Google Scholar
  18. 18.
    Hirschberg, E. &G. Merson. 1955. Effect of test compounds on the aggregation and culmination of the slime moldDictyostelium discoideum. Cancer Res. Suppl.3: 76–79.PubMedGoogle Scholar
  19. 19.
    Hitchings, G. H. 1958. Special microbiological systems III. The use of lactic acid bacteria for the evaluation of purine and pyrimidine antagonists. Ann. N. Y. Acad. Sci.76: 490–496.PubMedGoogle Scholar
  20. 20.
    Hitchings, G. H. &E. B. Elion. 1955. TheLactobacillus casei screening test. Cancer Res. Suppl.3: 66–68.PubMedGoogle Scholar
  21. 21.
    Hunter, S. H., H. A. Matham, S. Aaronson, H. Baker &S. Scher. 1958. General considerations in the use of microorganisms in screening antitumor agents. Ann. N. Y. Acad. Sci.76: 457–468.PubMedGoogle Scholar
  22. 22.
    Kaplan, L. 1954. Azaserine, an inhibitor of amino acid synthesis inE. coli. Fed. Proc.13: 239.Google Scholar
  23. 23.
    Karnofsky, D. A. 1955. Assay of chemotherapeutic agents of the developing chick embryo. Cancer Res. Suppl.3: 83–85.PubMedGoogle Scholar
  24. 24.
    Kohberger, D. L., H. C. Reilly, G. L. Coffey, A. B. Hillegas &J. Ehrlich. 1955. Azaserine yeast assay withKloeckera brevis. Antibiot. and Chemother.5, 2.Google Scholar
  25. 25.
    Maxwell, R. E. 1954. Filament formation inE. coli induced azaserine and other antineoplastic agents. Science120: 270–271.PubMedGoogle Scholar
  26. 26.
    McKenna, G. F., A. Taylor &N. Carmichael. 1958. Cancer chemotherapy with plant extracts. Texas Reports on Biol. Med.16: 203–214.Google Scholar
  27. 27.
    Mickelson, M. N. &R. S. Flippin. 1958. Effects of certain amino acid derivatives on microorganisms and Sarcoma 180. Excerpta Med. Cancer6.Google Scholar
  28. 28.
    Reilly, H. C. 1955. An evaluation of the use of anticrobial activity as a screening procedure for tumor inhibiting agents. Cancer Res. Suppl.3: 63–66.PubMedGoogle Scholar
  29. 29.
    Reilly, H. C. 1953. Microbiology and cancer therapy: A review. Cancer Res.13: 821–834.PubMedGoogle Scholar
  30. 30.
    Reilly, H. C., C. C. Stock, S. M. Buckley, D. A. Clarke &C. P. Rhoads. 1954. The screening of crude metabolic filtrates of soil microorganisms for ability to inhibit the growth of Sarcoma 180in vivo. Antibiotics Ann.: 1002–1008.Google Scholar
  31. 31.
    Schnabel, F. M. 1958. Utility of drug resistant organisms in cancer chemotherapy studies. Ann. N. Y. Acad. Sci.76: 442–456.PubMedGoogle Scholar
  32. 32.
    Schultz, J., N. Rothman &M. M. Aronson. 1955. The growth and morphogenesis ofDrosophila melanogaster as criteria for screening tests. Cancer Res. Suppl.3: 86–97.PubMedGoogle Scholar
  33. 33.
    Szybalski, W. 1958. Special microbiological systems II. Observations on chemical mutagenesis in microorganisms. Ann. N. Y. Acad. Sci.76: 467–489.Google Scholar
  34. 34.
    Woody, P. L., J. D. Mendell &J. Greenberg. 1961. Resistance and cross resistance ofEscherichia coli mutants to anticancer agents. Radiat. Res.15: 290–297.PubMedGoogle Scholar

Copyright information

© Uitgeverij Dr. W. Junk 1966

Authors and Affiliations

  • P. A. Volz
    • 1
  • E. S. Beneke
    • 1
  1. 1.Department of Botany and Plant PathologyMichigan State UniversityEast Lansing

Personalised recommendations